Scaffold proteins LACK and TRACK as potential drug targets in kinetoplastid parasites: Development of inhibitors
dc.citation.issue | 1 | |
dc.citation.volume | 6 | |
dc.contributor.author | Qvit, Nir | |
dc.contributor.author | Schechtman, Deborah | |
dc.contributor.author | Pena, Darlene Aparecida | |
dc.contributor.author | Berti, Denise Aparecida | |
dc.contributor.author | Soares, Chrislaine Oliveira | |
dc.contributor.author | Miao, Qianqian | |
dc.contributor.author | Liang, Liying (Annie) | |
dc.contributor.author | Baron, Lauren A. | |
dc.contributor.author | Teh-Poot, Christian | |
dc.contributor.author | Martinez-Vega, Pedro | |
dc.contributor.author | Ramirez-Sierra, Maria Jesus | |
dc.contributor.author | Churchill, Eric | |
dc.contributor.author | Cunningham, Anna D. | |
dc.contributor.author | Malkovskiy, Andrey V. | |
dc.contributor.author | Federspiel, Nancy A. | |
dc.contributor.author | Gozzo, Fabio Cesar | |
dc.contributor.author | Torrecilhas, Ana Claudia [UNIFESP] | |
dc.contributor.author | Manso Alves, Maria Julia | |
dc.contributor.author | Jardim, Armando | |
dc.contributor.author | Momar, Ndao | |
dc.contributor.author | Dumonteil, Eric | |
dc.contributor.author | Mochly-Rosen, Daria | |
dc.coverage | Oxford | |
dc.date.accessioned | 2020-07-22T13:23:21Z | |
dc.date.available | 2020-07-22T13:23:21Z | |
dc.date.issued | 2016 | |
dc.description.abstract | Parasitic diseases cause similar to 500,000 deaths annually and remain a major challenge for therapeutic development. Using a rational design based approach, we developed peptide inhibitors with anti-parasitic activity that were derived from the sequences of parasite scaffold proteins LACK (Leishmania's receptor for activated C-kinase) and TRACK (Trypanosoma receptor for activated C-kinase). We hypothesized that sequences in LACK and TRACK that are conserved in the parasites, but not in the mammalian ortholog, RACK (Receptor for activated C-kinase), may be interaction sites for signaling proteins that are critical for the parasites' viability. One of these peptides exhibited leishmanicidal and trypanocidal activity in culture. Moreover, in infected mice, this peptide was also effective in reducing parasitemia and increasing survival without toxic effects. The identified peptide is a promising new anti-parasitic drug lead, as its unique features may limit toxicity and drug-resistance, thus overcoming central limitations of most anti-parasitic drugs. (C) 2016 The Authors. Published by Elsevier Ltd on behalf of Australian Society for Parasitology. | en |
dc.description.affiliation | Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA | |
dc.description.affiliation | Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-05508 Sao Paulo, SP, Brazil | |
dc.description.affiliation | McGill Univ, Res Inst, Natl Reference Ctr Parasitol, Montreal, PQ, Canada | |
dc.description.affiliation | Univ Autonoma Yucatan, Ctr Invest Reg Dr Hideyo Noguchi, Parasitol Lab, Merida, Yucatan, Mexico | |
dc.description.affiliation | Stanford Univ, Biomat & Adv Drug Delivery Lab, Stanford, CA 94305 USA | |
dc.description.affiliation | Univ Estadual Campinas, Inst Chem, Campinas, SP, Brazil | |
dc.description.affiliation | Univ Fed Sao Paulo, Dept Ciencias Biol, Campus Diadema, Sao Paulo, Brazil | |
dc.description.affiliation | McGill Univ, Inst Parasitol, Quebec City, PQ, Canada | |
dc.description.affiliation | McGill Univ, Ctr Host Parasite Interact, Quebec City, PQ, Canada | |
dc.description.affiliationUnifesp | Univ Fed Sao Paulo, Dept Ciencias Biol, Campus Diadema, Sao Paulo, Brazil | |
dc.description.source | Web of Science | |
dc.description.sponsorship | National Institutes of Health | |
dc.description.sponsorshipID | NIH: TW008781-01C-IDEA | |
dc.description.sponsorshipID | NIH: AI078505 | |
dc.format.extent | 74-84 | |
dc.identifier | http://dx.doi.org/10.1016/j.ijpddr.2016.02.003 | |
dc.identifier.citation | International Journal For Parasitology-Drugs And Drug Resistance. Oxford, v. 6, n. 1, p. 74-84, 2016. | |
dc.identifier.doi | 10.1016/j.ijpddr.2016.02.003 | |
dc.identifier.file | WOS000372717200008.pdf | |
dc.identifier.issn | 2211-3207 | |
dc.identifier.uri | https://repositorio.unifesp.br/handle/11600/56191 | |
dc.identifier.wos | WOS:000372717200008 | |
dc.language.iso | eng | |
dc.publisher | Elsevier Sci Ltd | |
dc.relation.ispartof | International Journal For Parasitology-Drugs And Drug Resistance | |
dc.rights | info:eu-repo/semantics/openAccess | |
dc.subject | Chagas disease | en |
dc.subject | Leishmaniasis | en |
dc.subject | Peptide | en |
dc.subject | LACK | en |
dc.subject | TRACK | en |
dc.subject | Scaffold protein | en |
dc.title | Scaffold proteins LACK and TRACK as potential drug targets in kinetoplastid parasites: Development of inhibitors | en |
dc.type | info:eu-repo/semantics/article |
Arquivos
Pacote Original
1 - 1 de 1
Carregando...
- Nome:
- WOS000372717200008.pdf
- Tamanho:
- 1.42 MB
- Formato:
- Adobe Portable Document Format
- Descrição: